Cullinan Oncology Common
(CGEM)
|
21.0 |
$130M |
|
7.6M |
17.04 |
Geron Corporation Common
(GERN)
|
5.6 |
$35M |
|
11M |
3.30 |
Iovance Biotherapeutics Common
(IOVA)
|
5.2 |
$33M |
|
2.2M |
14.82 |
Zentalis Pharmaceuticals Common
(ZNTL)
|
3.8 |
$24M |
|
1.5M |
15.76 |
iTeos Therapeutics Common
(ITOS)
|
3.8 |
$24M |
|
1.7M |
13.64 |
Sutro Biopharma Common
(STRO)
|
3.7 |
$23M |
|
4.1M |
5.65 |
Crinetics Pharmaceuticals Common
(CRNX)
|
3.6 |
$23M |
|
481k |
46.81 |
Olema Pharmaceuticals Common
(OLMA)
|
3.6 |
$22M |
|
2.0M |
11.32 |
Madrigal Pharmaceuticals Common
(MDGL)
|
2.6 |
$16M |
|
61k |
267.04 |
Natera Common
(NTRA)
|
2.5 |
$16M |
|
172k |
91.46 |
Werewolf Therapeutics Common
(HOWL)
|
2.5 |
$16M |
|
2.4M |
6.48 |
Moonlake Immunotherapeutics Class A Ord
(MLTX)
|
2.4 |
$15M |
|
296k |
50.23 |
Avadel Pharmaceuticals Sponsored ADR
|
2.4 |
$15M |
|
871k |
16.89 |
Insmed Incorporated Common
(INSM)
|
2.3 |
$14M |
|
531k |
27.13 |
ALX Oncology Holdings Common
(ALXO)
|
2.3 |
$14M |
|
1.3M |
11.15 |
Viking Therapeutics Common
(VKTX)
|
2.0 |
$12M |
|
150k |
82.00 |
Intellia Therapeutics Common
(NTLA)
|
1.9 |
$12M |
|
433k |
27.51 |
Regenxbio Common
(RGNX)
|
1.9 |
$12M |
|
549k |
21.07 |
Ultragenyx Pharmaceutical Common
(RARE)
|
1.8 |
$12M |
|
246k |
46.69 |
Morphic Holding Common
(MORF)
|
1.8 |
$12M |
|
325k |
35.20 |
89Bio Common
(ETNB)
|
1.8 |
$11M |
|
968k |
11.64 |
Viridian Therapeutics Common
(VRDN)
|
1.7 |
$11M |
|
614k |
17.51 |
Fulcrum Therapeutics Common
(FULC)
|
1.7 |
$11M |
|
1.1M |
9.44 |
Xeris Biopharma Holdings Common
(XERS)
|
1.5 |
$9.2M |
|
4.2M |
2.21 |
Axsome Therapeutics Common
(AXSM)
|
1.5 |
$9.1M |
|
114k |
79.80 |
Kalvista Pharmaceuticals Common
(KALV)
|
1.5 |
$9.0M |
|
761k |
11.86 |
Revolution Medicines Common
(RVMD)
|
1.4 |
$8.8M |
|
273k |
32.23 |
Verve Therapeutics Common
(VERV)
|
1.4 |
$8.5M |
|
638k |
13.28 |
Amicus Therapeutics Common
(FOLD)
|
1.4 |
$8.5M |
|
719k |
11.78 |
Akero Therapeutics Common
(AKRO)
|
1.4 |
$8.4M |
|
333k |
25.26 |
Adaptimmune Therapeutics Sponsored ADR
(ADAP)
|
1.3 |
$8.1M |
|
5.1M |
1.58 |
Edgewise Therapeutics Common
(EWTX)
|
1.3 |
$8.0M |
|
441k |
18.24 |
Repare Therapeutics Common
(RPTX)
|
1.2 |
$7.7M |
|
1.6M |
4.71 |
Relay Therapeutics Common
(RLAY)
|
1.1 |
$6.9M |
|
832k |
8.30 |
Disc Medicine Common
(IRON)
|
1.1 |
$6.9M |
|
111k |
62.26 |
Trevi Therapeutics Common
(TRVI)
|
0.7 |
$4.6M |
|
1.3M |
3.45 |
Immatics NV Common
|
0.7 |
$4.2M |
|
395k |
10.51 |
Compass Therapeutics Common
(CMPX)
|
0.6 |
$3.9M |
|
2.0M |
1.98 |